Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

exchanges : Amex    crawled date : 2022 - 10 - 31    save search

TASEKO TO RELEASE THIRD QUARTER 2022 RESULTS
Published: 2022-10-31 (Crawled : 22:00) - prnewswire.com
TGB 5 d | $2.39 -4.02% 730K twitter stocktwits trandingview |
Non-Energy Minerals
| | O: 1.75% H: 4.31% C: 3.45%

results
Kaleyra to Report Third Quarter 2022 Financial Results on Monday, November 7, 2022 at 4:30 p.m. ET
Published: 2022-10-31 (Crawled : 21:00) - prnewswire.com
KLR | $7.24 0.0% 110K twitter stocktwits trandingview |
Communications
| | O: 0.63% H: 3.97% C: -0.64%

report financial results
AAMC Files Lawsuit Against Former Board Member Nathaniel Redleaf for Improperly Disclosing Confidential Information for Financial Gain
Published: 2022-10-31 (Crawled : 21:00) - globenewswire.com
AAMC 4 | $3.5 -7.53% 360 twitter stocktwits trandingview |
Finance
| | O: 2.29% H: 9.21% C: 6.91%

financial
Lineage Cell Therapeutics Appoints Jill Howe as Chief Financial Officer
Published: 2022-10-31 (Crawled : 15:00) - biospace.com/
PFE A | $25.84 -0.27% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.74% H: 0.65% C: -1.13%
GOSS 4 | $0.8426 -1.81% 55K twitter stocktwits trandingview |
Health Technology
| | O: -0.38% H: 6.05% C: 5.71%
LCTX | $1.225 -2.0% 110K twitter stocktwits trandingview |
Health Technology
| | O: 0.79% H: 10.24% C: 8.66%

therapeutics financial
Palatin Announces $10 Million Registered Direct Offering
Published: 2022-10-31 (Crawled : 14:00) - palatin.com
PTN | $1.88 3.3% 12K twitter stocktwits trandingview |
Health Technology
| | O: 0.34% H: 0.0% C: -5.13%

offering direct
Kaleyra Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
Published: 2022-10-31 (Crawled : 13:00) - prnewswire.com
KLR | $7.24 0.0% 110K twitter stocktwits trandingview |
Communications
| | O: -3.0% H: 6.15% C: 1.92%

communication program group
Actinium Announces Positive Top-line Results from Pivotal Phase 3 SIERRA Trial of Iomab-B in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia
Published: 2022-10-31 (Crawled : 11:00) - biospace.com/
ATNM | $8.27 -2.01% 35K twitter stocktwits trandingview |
Health Technology
| | O: 6.06% H: 34.59% C: 31.2%

active leukemia trial positive results acute myeloid leukemia
Gainers vs Losers
48% 52%

Top 10 Gainers
TPET | $0.4801 107.75% 16M twitter stocktwits trandingview |
n/a

JAGX | $0.23 93.6% 310M twitter stocktwits trandingview |
Health Technology

WISA 4 | $3.17 81.14% 36M twitter stocktwits trandingview |
Electronic Technology

PALI | $7.41 78.13% 14M twitter stocktwits trandingview |
Manufacturing

SPCB | $0.4278 55.0% 17M twitter stocktwits trandingview |
Electronic Technology

BTTR | $7.61 49.22% 1.8M twitter stocktwits trandingview |
Manufacturing

PRSO | $1.79 40.95% 25M twitter stocktwits trandingview |
Manufacturing

DYNT | $0.5203 40.47% 17M twitter stocktwits trandingview |
Health Technology

MCBC | $13.755 38.52% 620K twitter stocktwits trandingview |
Finance

SNGX | $0.5155 33.52% 3.9M twitter stocktwits trandingview |
Health Technology


Your saved searches
Save your searches and get alerts when important news are released.